封面
市場調查報告書
商品編碼
1386590

即時 PCR 和數位PCR 的全球市場:趨勢、預測和競爭分析(截至 2030 年)

Real-Time PCR and Digital PCR Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

即時PCR/數位PCR的趨勢和預測

預計2024年至2030年,全球即時PCR/數位PCR市場規模將以7.2%的年複合成長率成長,到2030年將達到約128億美元。該市場的主要促進因素是感染疾病的上升、PCR在生物標記發現中的使用不斷增加以及對分子檢測的日益偏好。全球即時 PCR 和數位PCR 市場的未來前景廣闊,醫院和診斷中心、實驗室和學術機構、製藥和生物技術、臨床研究機構和法醫學實驗室市場都充滿機會。

即時 PCR/數位PCR 市場洞察

Lucintel 預測臨床將在預測期內經歷最高的成長。

由於慢性病的高盛行率、新型尖端基因組產品的使用增加以及該地區主要參與者的存在,北美仍將是最大的地區。

本報告回答了 11 個關鍵問題:

  • Q.1. 細分市場中最有前途和高成長的機會是什麼?
  • Q.2.哪個細分市場將以更快的速度成長?為什麼?
  • Q.3.您認為哪些地區未來會出現更快的成長?為什麼?
  • Q.4. 影響市場動態的主要因素有哪些?市場的主要挑戰和商業風險是什麼?
  • Q.5. 這個市場的商業風險和競爭威脅是什麼?
  • Q.6.這個市場有哪些新趨勢?為什麼?
  • Q.7.市場客戶需求有何改變?
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位?
  • Q.9.這個市場的主要企業有哪些?主要企業採取哪些策略配合措施來發展業務?
  • Q.10. 該市場上的競爭產品有哪些?由於材料或產品替代而導致市場佔有率下降的威脅有多大?
  • Q.11.過去年度發生了哪些併購事件,對產業有何影響?

目錄

第1章 執行摘要

第2章 全球即時PCR/數位PCR市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢與預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球即時PCR/數位PCR市場趨勢(2018-2023)與預測(2024-2030)
  • 全球即時 PCR/數位PCR 市場:按產品類型
    • 試劑/消耗品
    • 裝置
    • 軟體
  • 全球即時 PCR/數位PCR 市場:依技術分類
    • 定量PCR
    • 數位PCR
  • 全球即時 PCR/數位PCR 市場:按應用分類
    • 臨床
    • 研究
    • 法醫學
    • 其他
  • 全球即時 PCR/數位PCR 市場:按最終用途
    • 醫院/診斷中心
    • 實驗室/學術機構
    • 製藥/生物技術
    • 臨床研究組織
    • 法醫學研究所
    • 其他

第4章 市場趨勢與預測分析:按地區(2018-2030)

  • 全球即時 PCR/數位PCR 市場:按地區
  • 北美即時PCR/數位PCR市場
  • 歐洲即時PCR/數位PCR市場
  • 亞太即時PCR/數位PCR市場
  • 其他地區即時PCR/數位PCR市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品類型分類的全球即時 PCR/數位PCR 市場成長機會
    • 全球即時 PCR 和數位PCR 市場的技術成長機會
    • 全球即時 PCR 和數位PCR 市場的成長機會(按應用)
    • 按最終用途分類的全球即時 PCR 和數位PCR 市場的成長機會
    • 按地區分類的全球即時 PCR 和數位PCR 市場的成長機會
  • 全球即時PCR/數位PCR市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球即時PCR和數位PCR市場的產能
    • 全球即時PCR和數位PCR市場的合併、收購和合資企業
    • 認證和許可

第7章 主要企業概況

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories
簡介目錄

Real-Time PCR and Digital PCR Trends and Forecast

The future of the global real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets. The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

A more than 150-page report is developed to help in your business decisions.

Real-Time PCR and Digital PCR by Segment

The study includes a forecast for the global real-time PCR and digital PCR by product type, technology, application, end use, and region.

Real-Time PCR and Digital PCR Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

  • Reagents and Consumables
  • Instruments
  • Software

Real-Time PCR and Digital PCR Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Quantitative PCR
  • Digital PCR

Real-Time PCR and Digital PCR Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Clinical
  • Research
  • Forensic
  • Others

Real-Time PCR and Digital PCR Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals and Diagnostic Centers
  • Research Laboratories and Academic Institutes
  • Pharmaceutical and Biotechnology
  • Clinical Research Organizations
  • Forensic Laboratories
  • Others

Real-Time PCR and Digital PCR Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Real-Time PCR and Digital PCR Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies real-time PCR and digital PCR companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the real-time PCR and digital PCR companies profiled in this report include-

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Real-Time PCR and Digital PCR Market Insights

Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Features of the Global Real-Time PCR and Digital PCR Market

Market Size Estimates: Real-time PCR and digital PCR market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Real-time PCR and digital PCR market size by various segments, such as by product type, technology, application, end use, and region in terms of ($B).

Regional Analysis: Real-time PCR and digital PCR market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the real-time PCR and digital PCR market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the real-time PCR and digital PCR market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the real-time PCR and digital PCR market size?

Answer: The global real-time PCR and digital PCR market is expected to reach an estimated $12.8 billion by 2030.

Q.2 What is the growth forecast for real-time PCR and digital PCR market?

Answer: The global real-time PCR and digital PCR market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the real-time PCR and digital PCR market?

Answer: The major drivers for this market are rising prevalence of infectious diseases, growing usage of PCR in biomarker discovery, and expanding preference for molecular testing.

Q4. What are the major segments for real-time PCR and digital PCR market?

Answer: The future of the real-time PCR and digital PCR market looks promising with opportunities in the hospital and diagnostic center, research laboratory and academic institute, pharmaceutical and biotechnology, clinical research organization, and forensic laboratory markets.

Q5. Who are the key real-time PCR and digital PCR market companies?

Answer: Some of the key real-time PCR and digital PCR companies are as follows:

  • F. Hoffmann La Roche
  • Takara Bio
  • Becton and Dickinson
  • Agilent Technologies
  • Merck KGaA
  • Qiagen
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher
  • Bio Rad Laboratories

Q6. Which real-time PCR and digital PCR market segment will be the largest in future?

Answer: Lucintel forecasts that clinical is expected to witness highest growth over the forecast period.

Q7. In real-time PCR and digital PCR market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to high prevalence of chronic diseases, increasing use of novel and cutting-edge genomic analysis products, and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the real-time PCR and digital PCR market by product type (reagents and consumables, instruments, and software), technology (quantitative PCR and digital PCR), application (clinical, research, forensic, and others), end use (hospitals and diagnostic centers, research laboratories and academic institutes, pharmaceutical and biotechnology, clinical research organizations, forensic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Real-Time PCR and Digital PCR Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Real-Time PCR and Digital PCR Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Real-Time PCR and Digital PCR Market by Product Type
    • 3.3.1: Reagents and Consumables
    • 3.3.2: Instruments
    • 3.3.3: Software
  • 3.4: Global Real-Time PCR and Digital PCR Market by Technology
    • 3.4.1: Quantitative PCR
    • 3.4.2: Digital PCR
  • 3.5: Global Real-Time PCR and Digital PCR Market by Application
    • 3.5.1: Clinical
    • 3.5.2: Research
    • 3.5.3: Forensic
    • 3.5.4: Others
  • 3.6: Global Real-Time PCR and Digital PCR Market by End Use
    • 3.6.1: Hospitals and Diagnostic Centers
    • 3.6.2: Research Laboratories and Academic Institutes
    • 3.6.3: Pharmaceutical and Biotechnology
    • 3.6.4: Clinical Research Organizations
    • 3.6.5: Forensic Laboratories
    • 3.6.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Real-Time PCR and Digital PCR Market by Region
  • 4.2: North American Real-Time PCR and Digital PCR Market
    • 4.2.1: North American Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.2.2: North American Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.3: European Real-Time PCR and Digital PCR Market
    • 4.3.1: European Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.3.2: European Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.4: APAC Real-Time PCR and Digital PCR Market
    • 4.4.1: APAC Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.4.2: APAC Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others
  • 4.5: ROW Real-Time PCR and Digital PCR Market
    • 4.5.1: ROW Real-Time PCR and Digital PCR Market by Application: Clinical, Research, Forensic, and Others
    • 4.5.2: ROW Real-Time PCR and Digital PCR Market by End Use: Hospitals and Diagnostic Centers, Research Laboratories and Academic Institutes, Pharmaceutical and Biotechnology, Clinical Research Organizations, Forensic Laboratories, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Product Type
    • 6.1.2: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Technology
    • 6.1.3: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Application
    • 6.1.4: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by End Use
    • 6.1.5: Growth Opportunities for the Global Real-Time PCR and Digital PCR Market by Region
  • 6.2: Emerging Trends in the Global Real-Time PCR and Digital PCR Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Real-Time PCR and Digital PCR Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Real-Time PCR and Digital PCR Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann La Roche
  • 7.2: Takara Bio
  • 7.3: Becton and Dickinson
  • 7.4: Agilent Technologies
  • 7.5: Merck KGaA
  • 7.6: Qiagen
  • 7.7: Abbott Laboratories
  • 7.8: Thermo Fisher Scientific
  • 7.9: Danaher
  • 7.10: Bio Rad Laboratories